Evidence map›Paper›PMID 41127705›Full record

ArticleThe Lancet regional health. Western Pacific2025

Community-based versus facility-based services to improve hepatitis C screening in Cambodia: a cluster randomized controlled trial (ANRS 12384 Cam-C study).

Dyna Khuon, Luis Sagaon-Teyssier, Sansothy Neth, Saly Saint, Laurence Meyer, Emilie Mosnier, Diana Molino, Chan Leakhena Phoeung, Chhingsrean Chhay, Kimeang Heang and 4 more

Registry-linked trialAbstract read
In one paragraph

Article in The Lancet regional health. Western Pacific, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03992313 (Community Versus Facility-based Services to Improve the Screening of Active HCV Infection in Cambodia), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03992313 nacompletednot on this map

Community Versus Facility-based Services to Improve the Screening of Active HCV Infection in Cambodia: a Cluster Randomized Controlled Trial

TypeinterventionalSponsorANRS, Emerging Infectious DiseasesRan2022 to 2023Enrolled7,692ConditionsHepatitis C, TestingArmsCommunity-based HCV rapid test, Facility-based HCV rapid test, Plasmatic HCV viral load, DBS HCV viral load
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Dyna KhuonUniversity of Health Sciences, Phnom Penh, Cambodia.
Luis Sagaon-TeyssierUniversity of Health Sciences, Phnom Penh, Cambodia.
Sansothy NethUniversity of Health Sciences, Phnom Penh, Cambodia.
Saly SaintUniversity of Health Sciences, Phnom Penh, Cambodia.
Laurence MeyerINSERM CESP U1018, Paris Saclay University, Le Kremlin-Bicêtre, Paris, France.
Emilie MosnierAix Marseille Univ, Inserm, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France.
Diana MolinoNational Institute of Health and Medical Research (Inserm), ANRS Emerging Infectious Diseases (ANRS MIE), Paris, France.
Chan Leakhena PhoeungUniversity of Health Sciences, Phnom Penh, Cambodia.
Chhingsrean ChhayUniversity of Health Sciences, Phnom Penh, Cambodia.
Kimeang HeangUniversity of Health Sciences, Phnom Penh, Cambodia.
Sovatha MamUniversity of Health Sciences, Phnom Penh, Cambodia.
Jean-Charles Duclos-ValléeINSERM CESP U1018, Paris Saclay University, Le Kremlin-Bicêtre, Paris, France.
Olivier SégéralHIV Unit, Infectious Diseases Department, Geneva University Hospital, Geneva, Switzerland.
Vonthanak SaphonnUniversity of Health Sciences, Phnom Penh, Cambodia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The estimated prevalence of hepatitis C virus (HCV) infection among adults aged over 45 years in Cambodia is approximately 5%. The present study aimed assessing the effectiveness of a novel community-based strategy comprising HCV rapid testing (RDT) and dried blood spot (DBS) collection performed by community health workers (CHWs) in outreach contexts. Methods: ANRS 12384 Cam-C is a parallel arm cluster randomized controlled trial conducted in the Siem Reap and Kampong Cham provinces of Cambodia between April 2022 and September 2023. Four geographical areas in each province were randomized into two arms to compare HCV RDT and DBS collection provided in homes by community health workers (i.e., community-based strategy) with facility-based HCV RDT and whole blood collection provided by healthcare workers in health centers (i.e., facility-based strategy). The primary outcome was combined testing uptake, defined as the proportion of participants who were actually tested for HCV using RDT or RDT/RNA if positive out of all those who participated in the study. Mixed effects logistic models were used to estimate the effect of the community-based strategy. The study is registered on ClinicalTrials.gov (NCT03992313). Findings: Among the 7692 participants who initially enrolled in the study, 5590 (72.7%) actually went on to have HCV RDT or HCV RDT/RNA screening (i.e., combined testing uptake). Combined testing uptake in the community-based (2990 participants) and facility-based (2600 participants) arms was 78.1% and 67.3%, respectively (p < 0.001). Positive HCV RDT was found for 57 (2.2%) including 39 (1.5%) with detectable HCV RNA among participants in the facility-based arm. In the community-based arm, 37 (1.2%) had positive HCV RDT including 32 (1.1%) with detectable HCV RNA. Treatment uptake concerned 36 participants (out of 39 with positive HCV RDT) and 30 (out of 32) in the facility-based and community-based arms, respectively. The odds of combined testing uptake in the community-based strategy were 2.18 (95% CI [1.28-3.73], p = 0.004) times higher than in the facility-based strategy. Interpretation: Combined testing uptake (HCV RDT or HCV RDT/RNA) was higher for the community-based strategy than for the facility-based strategy. The involvement of community health workers improved first contact with HCV services and uptake. Integrating this trial's community-based screening strategy into the national Cambodian HCV program could improve its effectiveness as part of the country's broader goal of eliminating HCV by 2030. Funding: This study was supported by the ANRS MIE (ANRS 12384).

Indexed as

Active HCV infection detectionCambodiaCluster randomized trialCommunity-based strategyHCVHepatitis CPoint-of-careRapid diagnostic test uptake

Identifiers

PMID41127705
PMCPMC12538039

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.